SCHEMBL2462935

SCHEMBL2462935

c1ncc(-c2ccc3ocnc3c2)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.49
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
IDO1 P14902 7/20 0.45
ASIC3 Q9UHC3 2/20 0.45
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP3A4 P08684 3/20 0.43
HPGDS O60760 1/20 0.41
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP2D6 P10635 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2E1 P05181 1/20 0.40
CYP2A6 P11509 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
LTA4H P09960 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2458494 0.89 DYRK1A (0.50) DYRK1ACYP11B1CYP11B2IDO1ASIC3
SCHEMBL28048555 0.77 DYRK1A (0.72) DYRK1ASMN1; SMN2
SCHEMBL2455614 0.76 DYRK1A (0.50) DYRK1ASMN1; SMN2
SCHEMBL2457798 0.75 CYP11B1 (0.47) CYP11B1CYP11B2IDO1ASIC3POLB
SCHEMBL30718016 0.73 CYP11B1 (0.53) CYP11B1CYP11B2IDO1ASIC3POLB
SCHEMBL2462078 0.73 CYP11B1 (0.57) DYRK1ACYP11B1CYP11B2IDO1ASIC3
SCHEMBL2457424 0.73 DYRK1A (0.50) DYRK1APOLBSMN1; SMN2CYP3A4HPGDS
SCHEMBL16005249 0.72 DYRK1A (0.53) DYRK1ACYP11B1CYP11B2CYP3A4CYP2D6
SCHEMBL991450 0.72 CYP11B1 (0.51) CYP11B1CYP11B2IDO1ASIC3POLB
SCHEMBL2457834 0.72 DYRK1A (0.49) DYRK1ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET DYRK1A 4134/4885CYP11B1 2027/4885CYP11B2 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.